These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy]. Kaftański R Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275 [TBL] [Abstract][Full Text] [Related]
23. The study of T-lymphocytes, granulocyte's phagocytic activity, and adherent cells in patients with acute lymphoblastic leukemia during levamisol therapy. Bogusławska-Jaworska J; Chybicka A; Pisarek J Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):855-8. PubMed ID: 312090 [TBL] [Abstract][Full Text] [Related]
24. [Advances in the treatment of acute lymphoblastic leukemia in childhood (author's transl)]. Krpan-Antonin N Lijec Vjesn; 1980 Feb; 102(3):153-6. PubMed ID: 6931274 [No Abstract] [Full Text] [Related]
25. [Cessation of chemotherapy in acute lymphoblastic leukemia. Probable cures and post-suppression relapses]. Ortega JJ; Javier G Sangre (Barc); 1982; 27(5):899-911. PubMed ID: 6963002 [No Abstract] [Full Text] [Related]
26. [Results in the treatment of acute lymphoblastic and acute myeloblastic leukemia in children (using Pinkel's and Clarkson's schedules)]. Tiefenbach A; Potkonjak-Sekso M; Konja J Bilt Hematol Transfuz; 1976; 4(1-2):71-5. PubMed ID: 1066128 [TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group. Miller DR; Leikin S; Albo V; Sather H; Karon M; Hammond D Cancer; 1983 Mar; 51(6):1041-9. PubMed ID: 6336986 [No Abstract] [Full Text] [Related]
29. [Results of intensive treatment of children during the 1st remission of acute lymphoblastic leukemia]. Armata J Pol Tyg Lek; 1973; 28(39):1500-2. PubMed ID: 4518635 [No Abstract] [Full Text] [Related]
30. [Treatment of acute leukemias]. Stefanović S; Ristić M; Banićević B Bilt Hematol Transfuz; 1976; 4(1-2):9-17. PubMed ID: 1066130 [TBL] [Abstract][Full Text] [Related]
31. Advances in therapy and classification of the acute leukemias. Miller KB Compr Ther; 1986 Aug; 12(8):48-53. PubMed ID: 3461900 [No Abstract] [Full Text] [Related]
32. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators. Holland JF; Ohnuma T Cancer Treat Rep; 1981; 65 Suppl 4():123-30. PubMed ID: 7049376 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of acute childhood leukemia. A new protocol 811 for the standard risk group of acute lymphocytic leukemia (Phase III study)]. Koizumi S; Fujimoto T; Higashi O; Utsumi J; Mimaya J; Sekine I; Shike S; Imashuku S; Yamamoto S; Ninomiya T Rinsho Ketsueki; 1983 Dec; 24(12):1633-40. PubMed ID: 6368900 [No Abstract] [Full Text] [Related]
34. [Treatment of acute lymphoblastic leukemia]. Weil M; Auclerc MF; Jacquillat C Rev Infirm; 1980 Feb; 30(2):25-8. PubMed ID: 6928699 [No Abstract] [Full Text] [Related]
35. [Prognosis of acute leukemias]. Bernard J; Jacquillat C; Weil M Recenti Prog Med; 1975 Sep; 59(3):266-73. PubMed ID: 1063423 [No Abstract] [Full Text] [Related]